About

As a seasoned freelance creative with a strong background in the art world, I bring over 15 years of experience as a creative director in the healthcare sector. My work has spanned across the East and West coasts, encompassing a wide range of therapeutic categories, from CNS disorders to Oncology and rare orphan diseases. My expertise lies in crafting experiential experiences, managing creativity, developing concepts, AI Conjuring, branding, exhibit design, and Interactive media.

My recent achievements include the successful launch of Mavacamten, a groundbreaking treatment for HCM, for BMS. I am also at the helm of the launch of BMS/Celgene AML maintenance treatment, ONUREG. These experiences have honed my skills and deepened my understanding of blood cancer therapies.

Besides a strong background in blood cancers, I have launched the global and US indications of Afinitor, the Novartis treatment for Breast, PNET, and Kidney cancers, as well as the launch of Xalkori, the Pfizer treatment for ALK targeted lung cancer. He also launched TAFINLAR and MEKINIST, the Novartis treatments for patients with metastatic non-small cell lung cancer.

My career journey began on the West Coast at FCB, and I later made a move to Cambridge, MA. Here, I played a pivotal role in founding the Cambridge BioMarketing group, where I led the agency’s creative direction for nine years. During this time, we achieved significant milestones, winning numerous awards and accolades.

I’m also an avid art collector and publish an art gallery guide for Chelsea, NYC, called West of Dirty. Follow me on Instagram to see what’s happening in the world of art @westofdirty

About

Info